|
SEPT11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.33319999999915E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.864600E-03 |
| Normal-vs-Stage2 |
4.121300E-03 |
| Normal-vs-Stage3 |
2.116600E-03 |
| Normal-vs-Stage4 |
2.37839999994716E-06 |
| Stage1-vs-Stage2 |
5.021600E-01 |
| Stage1-vs-Stage3 |
2.424200E-01 |
| Stage1-vs-Stage4 |
2.549700E-02 |
| Stage2-vs-Stage3 |
6.135000E-01 |
| Stage2-vs-Stage4 |
2.035800E-01 |
| Stage3-vs-Stage4 |
4.500600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.004690E-03 |
| Normal-vs-AfricanAmerican |
2.98669999998502E-06 |
| Normal-vs-Asian |
1.85879999999861E-05 |
| Caucasian-vs-AfricanAmerican |
1.842450E-01 |
| Caucasian-vs-Asian |
3.459900E-02 |
| AfricanAmerican-vs-Asian |
1.490210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16340000003257E-06 |
| Normal-vs-Female |
2.629800E-01 |
| Male-vs-Female |
1.954760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.255300E-03 |
| Normal-vs-Extreme_Weight |
2.902300E-03 |
| Normal-vs-Obese |
4.006100E-02 |
| Normal-vs-Extreme_Obese |
1.096790E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.449200E-01 |
| Normal_Weight-vs-Obese |
2.819200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.870000E-01 |
| Extreme_Weight-vs-Obese |
4.028600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.632400E-01 |
| Obese-vs-Extreme_Obese |
4.977600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.968300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.196300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.04560000002696E-06 |
| Normal-vs-Age(81-100Yrs) |
1.824100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.396800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.041200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.551800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.731600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.647500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.441000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.520460E-02 |
| Normal-VS-Type2 PRCC |
2.04310000029295E-08 |
| Normal-VS-KIRP CIMP |
4.836300E-03 |
| Normal-VS-Unclassified PRCC |
1.794240E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.335210E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.329200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.410800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.512800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.590200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.597000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.93820000446732E-08 |
| Normal-vs-N1 |
8.05060000000912E-05 |
| Normal-vs-N2 |
1.080270E-02 |
| N0-vs-N1 |
9.969400E-01 |
| N0-vs-N2 |
8.489600E-01 |
| N1-vs-N2 |
8.583200E-01 |
|
|
